Skip to main content
. 2021 Apr 15;29(5):e282–e286. doi: 10.1097/IPC.0000000000001023

TABLE 3.

Comparison of Clinical Outcomes Between Patients Initiated on Remdesivir Therapy ≤3 Days Versus >3 Days of First Positive SARS-CoV-2 PCR Test

Initiation of Remdesivir From PCR Positive Test ≤3 Days >3 Days Significance
Total n (%) 421 (88.6) 54 (11.3)
Length of stay P = 0.03
 Mean 15.7 19.3
 SD 12 10.9
 Minimum 2 7
 Maximum 63 64
Need for mechanical ventilation 127 (30%) 21 (39%) (OR, 1.5; CI, 0.8–2.7) P = 0.19
Death 82 (19.4%) 16 (29.6%) (OR, 1.74; CI, 0.9–3.2) P = 0.08